{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:08Z","timestamp":1792787828215,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["822300620"],"award-info":[{"award-number":["822300620"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Zhejiang Province","award":["LY19H090023"],"award-info":[{"award-number":["LY19H090023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05180-1","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:13:09Z","timestamp":1784380389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genotype-phenotype relationship in a cohort of 131 Chinese patients with myotonic dystrophy type 1"],"prefix":"10.1186","volume":"26","author":[{"given":"Li-Ying","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Mei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-572X","authenticated-orcid":false,"given":"Zhi-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-5516","authenticated-orcid":false,"given":"Gong-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"3","key":"5180_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nmd.2017.12.011","volume":"28","author":"G Boussa\u00efd","year":"2018","unstructured":"Boussa\u00efd G, Wahbi K, Laforet P, Eymard B, Stojkovic T, Behin A, Djillali A, Orlikowski D, Prigent H, Lofaso F. Genotype and other determinants of respiratory function in myotonic dystrophy type 1. Neuromuscul Disord. 2018;28(3):222\u20138. https:\/\/doi.org\/10.1016\/j.nmd.2017.12.011.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"5180_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","volume":"68","author":"JD Brook","year":"1992","unstructured":"Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion J-P, Hudson T, et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell. 1992;68(4):799\u2013808. https:\/\/doi.org\/10.1016\/0092-8674(92)90154-5.","journal-title":"Cell"},{"issue":"6360","key":"5180_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/355547a0","volume":"355","author":"J Buxton","year":"1992","unstructured":"Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, Aslanidis C, de Jong P, Jansen G, Anvret M, Riley B. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992;355(6360):547\u20138. https:\/\/doi.org\/10.1038\/355547a0.","journal-title":"Nature"},{"issue":"5049","key":"5180_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1126\/science.1546326","volume":"255","author":"YH Fu","year":"1992","unstructured":"Fu YH, Pizzuti A, Fenwick RG Jr., King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255(5049):1256\u20138. https:\/\/doi.org\/10.1126\/science.1546326.","journal-title":"Science"},{"issue":"10","key":"5180_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","volume":"172","author":"M De Antonio","year":"2016","unstructured":"De Antonio M, Dogan C, Hamroun D, Mati M, Zerrouki S, Eymard B, Katsahian S, Bassez G. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Rev Neurol (Paris). 2016;172(10):572\u201380. https:\/\/doi.org\/10.1016\/j.neurol.2016.08.003.","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"5180_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2020.00277","volume":"2","author":"A Magee","year":"1999","unstructured":"Magee A, Nevin NC. The epidemiology of myotonic dystrophy in Northern Ireland. Community Genet. 1999;2(4):179\u201383. https:\/\/doi.org\/10.3389\/fneur.2020.00277.","journal-title":"Community Genet"},{"issue":"Pt 11","key":"5180_CR7","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1093\/brain\/awp236","volume":"132","author":"FL Norwood","year":"2009","unstructured":"Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132(Pt 11):3175\u201386. https:\/\/doi.org\/10.1093\/brain\/awp236.","journal-title":"Brain"},{"issue":"5","key":"5180_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1034\/j.1399-0004.2001.590508.x","volume":"59","author":"G Siciliano","year":"2001","unstructured":"Siciliano G, Manca M, Gennarelli M, Angelini C, Rocchi A, Iudice A, Miorin M, Mostacciuolo M. Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. Clin Genet. 2001;59(5):344\u20139. https:\/\/doi.org\/10.1034\/j.1399-0004.2001.590508.x.","journal-title":"Clin Genet"},{"issue":"7","key":"5180_CR9","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1212\/WNL.0000000000011425","volume":"96","author":"NE Johnson","year":"2021","unstructured":"Johnson NE, Butterfield RJ, Mayne K, Newcomb T, Imburgia C, Dunn D, Duval B, Feldkamp ML, Weiss RB. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program. Neurology. 2021;96(7):e1045\u201353. https:\/\/doi.org\/10.1212\/WNL.0000000000011425.","journal-title":"Neurology"},{"issue":"8767","key":"5180_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/0140-6736(91)90659-d","volume":"338","author":"T Ashizawa","year":"1991","unstructured":"Ashizawa T, Epstein HF. Ethnic distribution of myotonic dystrophy gene. Lancet. 1991;338(8767):642\u20133. https:\/\/doi.org\/10.1016\/0140-6736(91)90659-d.","journal-title":"Lancet"},{"issue":"1","key":"5180_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1469-1809.1996.tb01172.x","volume":"60","author":"A Goldman","year":"1996","unstructured":"Goldman A, Ramsay M, Jenkins T. Ethnicity and myotonic dystrophy: a possible explanation for its absence in sub-Saharan Africa. Ann Hum Genet. 1996;60(1):57\u201365. https:\/\/doi.org\/10.1111\/j.1469-1809.1996.tb01172.x.","journal-title":"Ann Hum Genet"},{"issue":"5","key":"5180_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000071191","volume":"22","author":"KM Hsiao","year":"2003","unstructured":"Hsiao KM, Chen SS, Li SY, Chiang SY, Lin HM, Pan H, Huang CC, Kuo HC, Jou SB, Su CC, et al. Epidemiological and genetic studies of myotonic dystrophy type 1 in Taiwan. Neuroepidemiology. 2003;22(5):283\u20139. https:\/\/doi.org\/10.1159\/000071191.","journal-title":"Neuroepidemiology"},{"issue":"12","key":"5180_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.nmd.2009.08.009","volume":"19","author":"R Thompson","year":"2009","unstructured":"Thompson R, Schoser B, Monckton DG, Blonsky K, Lochmuller H. Patient Registries and Trial Readiness in Myotonic Dystrophy\u2013TREAT-NMD\/Marigold International Workshop Report. Neuromuscul Disord. 2009;19(12):860\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2009.08.009.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"5180_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13023-018-0889-0","volume":"13","author":"L Wood","year":"2018","unstructured":"Wood L, Bassez G, Bleyenheuft C, Campbell C, Cossette L, Jimenez-Moreno AC, Dai Y, Dawkins H, Manera JAD, Dogan C, et al. Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease. Orphanet J Rare Dis. 2018;13(1):155. https:\/\/doi.org\/10.1186\/s13023-018-0889-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"5180_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1212\/wnl.56.3.336","volume":"56","author":"J Mathieu","year":"2001","unstructured":"Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56(3):336\u201340. https:\/\/doi.org\/10.1212\/wnl.56.3.336.","journal-title":"Neurology"},{"key":"5180_CR16","doi-asserted-by":"publisher","first-page":"120080","DOI":"10.1016\/j.jns.2021.120080","volume":"432","author":"M Sugimoto","year":"2022","unstructured":"Sugimoto M, Kuru S, Takada H, Horie R, Yamauchi K, Kubota T, Matsumura T, Nakamura H, Kimura E, Takahashi MP. Characteristics of myotonic dystrophy patients in the national registry of Japan. J Neurol Sci. 2022;432:120080. https:\/\/doi.org\/10.1016\/j.jns.2021.120080.","journal-title":"J Neurol Sci"},{"issue":"3","key":"5180_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JND-190397","volume":"6","author":"E van der Plas","year":"2019","unstructured":"van der Plas E, Hamilton MJ, Miller JN, Koscik TR, Long JD, Cumming S, Povilaikaite J, Farrugia ME, McLean J, Jampana R, et al. Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats. J Neuromuscul Dis. 2019;6(3):321\u201332. https:\/\/doi.org\/10.3233\/JND-190397.","journal-title":"J Neuromuscul Dis"},{"key":"5180_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fneur.2020.00277","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Wang Z, Cui F, Yang F, Wang H, Huang X. Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1. Front Neurol. 2020;11:277. https:\/\/doi.org\/10.3389\/fneur.2020.00277.","journal-title":"Front Neurol"},{"issue":"2","key":"5180_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/2394-8108.186282","volume":"2","author":"H Lu","year":"2016","unstructured":"Lu H, Li Y, Sadowsky M, Da Y. Clinical characteristics of 37 Chinese patients with myotonic dystrophy Type 1. Brain Circ. 2016;2(2):95\u20138. https:\/\/doi.org\/10.4103\/2394-8108.186282.","journal-title":"Brain Circ"},{"issue":"1","key":"5180_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13023-024-03114-z","volume":"19","author":"H Zhong","year":"2024","unstructured":"Zhong H, Zeng L, Yu X, Ke Q, Dong J, Chen Y, Luo L, Chang X, Guo J, Wang Y, et al. Clinical features and genetic spectrum of a multicenter Chinese cohort with myotonic dystrophy type 1. Orphanet J Rare Dis. 2024;19(1):103. https:\/\/doi.org\/10.1186\/s13023-024-03114-z.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"5180_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/WNL.0000000000004300","volume":"89","author":"K Okkersen","year":"2017","unstructured":"Okkersen K, Monckton DG, Le N, Tuladhar AM, Raaphorst J, van Engelen BGM. Brain imaging in myotonic dystrophy type 1: A systematic review. Neurology. 2017;89(9):960\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000004300.","journal-title":"Neurology"},{"issue":"2","key":"5180_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-0404.2007.00911.x","volume":"117","author":"HC Kuo","year":"2008","unstructured":"Kuo HC, Hsieh YC, Wang HM, Chuang WL, Huang CC. Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1. Acta Neurol Scand. 2008;117(2):101\u20137. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00911.x.","journal-title":"Acta Neurol Scand"},{"issue":"Pt 12","key":"5180_CR23","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1093\/brain\/awr299","volume":"134","author":"M Minnerop","year":"2011","unstructured":"Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, et al. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain. 2011;134(Pt 12):3530\u201346. https:\/\/doi.org\/10.1093\/brain\/awr299.","journal-title":"Brain"},{"issue":"4","key":"5180_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"5180_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-510x(93)90041-v","volume":"114","author":"P Scheltens","year":"1993","unstructured":"Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114(1):7\u201312. https:\/\/doi.org\/10.1016\/0022-510x(93)90041-v.","journal-title":"J Neurol Sci"},{"issue":"5","key":"5180_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/hmg\/3.5.819","volume":"3","author":"H Yamagata","year":"1994","unstructured":"Yamagata H, Miki T, Sakoda S, Yamanaka N, Davies J, Shelbourne P, Kubota R, Takenaga S, Nakagawa M, Ogihara T, et al. Detection of a premutation in Japanese myotonic dystrophy. Hum Mol Genet. 1994;3(5):819\u201320. https:\/\/doi.org\/10.1093\/hmg\/3.5.819.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"5180_CR27","doi-asserted-by":"publisher","first-page":"e0148264","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, et al. Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study. PLoS ONE. 2016;11(2):e0148264. https:\/\/doi.org\/10.1371\/journal.pone.0148264.","journal-title":"PLoS ONE"},{"issue":"2","key":"5180_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF00887824","volume":"242","author":"A Jaspert","year":"1995","unstructured":"Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol. 1995;242(2):99\u2013104. https:\/\/doi.org\/10.1007\/BF00887824.","journal-title":"J Neurol"},{"issue":"1","key":"5180_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1034\/j.1399-0004.2000.570112.x","volume":"57","author":"C Marchini","year":"2000","unstructured":"Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet. 2000;57(1):74\u201382. https:\/\/doi.org\/10.1034\/j.1399-0004.2000.570112.x.","journal-title":"Clin Genet"},{"issue":"1","key":"5180_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1006\/bmmb.1993.1049","volume":"50","author":"G Novelli","year":"1993","unstructured":"Novelli G, Gennarelli M, Menegazzo E, Mostacciuolo ML, Pizzuti A, Fattorini C, Tessarolo D, Tomelleri G, Giacanelli M, Danieli GA, et al. (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol. 1993;50(1):85\u201392. https:\/\/doi.org\/10.1006\/bmmb.1993.1049.","journal-title":"Biochem Med Metab Biol"},{"issue":"6","key":"5180_CR31","first-page":"1164","volume":"52","author":"HG Harley","year":"1993","unstructured":"Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, Reardon W, Fenton I, Shaw DJ, Harper PS. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet. 1993;52(6):1164\u201374.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"5180_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jmg.36.1.59","volume":"36","author":"MG Hamshere","year":"1999","unstructured":"Hamshere MG, Harley H, Harper P, Brook JD, Brookfield JF. Myotonic dystrophy: the correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions. J Med Genet. 1999;36(1):59\u201361.","journal-title":"J Med Genet"},{"issue":"2","key":"5180_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/humu.10027","volume":"19","author":"D Savic","year":"2002","unstructured":"Savic D, Rakocvic-Stojanovic V, Keckarevic D, Culjkovic B, Stojkovic O, Mladenovic J, Todorovic S, Apostolski S, Romac S. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1. Hum Mutat. 2002;19(2):131\u20139. https:\/\/doi.org\/10.1002\/humu.10027.","journal-title":"Hum Mutat"},{"issue":"10","key":"5180_CR34","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1212\/WNL.0000000000008056","volume":"93","author":"SA Cumming","year":"2019","unstructured":"Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, Littleford R, Gorman G, Bassez G, Schoser B, et al. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 2019;93(10):e995\u20131009. https:\/\/doi.org\/10.1212\/WNL.0000000000008056.","journal-title":"Neurology"},{"issue":"14","key":"5180_CR35","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1073\/pnas.94.14.7388","volume":"94","author":"BM Davis","year":"1997","unstructured":"Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE. Expansion of a CUG trinucleotide repeat in the 3\u2019 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A. 1997;94(14):7388\u201393. https:\/\/doi.org\/10.1073\/pnas.94.14.7388.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"5180_CR36","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41431-018-0156-9","volume":"26","author":"SA Cumming","year":"2018","unstructured":"Cumming SA, Hamilton MJ, Robb Y, Gregory H, McWilliam C, Cooper A, Adam B, McGhie J, Hamilton G, Herzyk P, et al. De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1. Eur J Hum Genet. 2018;26(11):1635\u201347. https:\/\/doi.org\/10.1038\/s41431-018-0156-9.","journal-title":"Eur J Hum Genet"},{"issue":"13","key":"5180_CR37","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/hmg\/ddz055","volume":"28","author":"G Overend","year":"2019","unstructured":"Overend G, L\u00e9gar\u00e9 C, Mathieu J, Bouchard L, Gagnon C, Monckton DG. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet. 2019;28(13):2245\u201354. https:\/\/doi.org\/10.1093\/hmg\/ddz055.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"5180_CR38","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/ajmg.a.32987","volume":"149a","author":"Z Musova","year":"2009","unstructured":"Musova Z, Mazanec R, Krepelova A, Ehler E, Vales J, Jaklova R, Prochazka T, Koukal P, Marikova T, Kraus J, et al. Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene. Am J Med Genet A. 2009;149a(7):1365\u201374. https:\/\/doi.org\/10.1002\/ajmg.a.32987.","journal-title":"Am J Med Genet A"},{"issue":"8","key":"5180_CR39","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/hmg\/ddq015","volume":"19","author":"C Braida","year":"2010","unstructured":"Braida C, Stefanatos RK, Adam B, Mahajan N, Smeets HJ, Niel F, Goizet C, Arveiler B, Koenig M, Lagier-Tourenne C, et al. Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients. Hum Mol Genet. 2010;19(8):1399\u2013412. https:\/\/doi.org\/10.1093\/hmg\/ddq015.","journal-title":"Hum Mol Genet"},{"key":"5180_CR40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fgene.2018.00601","volume":"9","author":"J Pe\u0161ovi\u0107","year":"2018","unstructured":"Pe\u0161ovi\u0107 J, Peri\u0107 S, Brku\u0161anin M, Braju\u0161kovi\u0107 G, Rako\u010devi\u0107-Stojanovi\u0107 V, Savi\u0107-Pavi\u0107evi\u0107 D. Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing DMPK Expansions in Somatic Cells. Front Genet. 2018;9:601. https:\/\/doi.org\/10.3389\/fgene.2018.00601.","journal-title":"Front Genet"},{"issue":"2","key":"5180_CR41","doi-asserted-by":"publisher","first-page":"e572","DOI":"10.1212\/nxg.0000000000000572","volume":"7","author":"S Wenninger","year":"2021","unstructured":"Wenninger S, Cumming SA, Gutschmidt K, Okkersen K, Jimenez-Moreno AC, Daidj F, Lochm\u00fcller H, Hogarth F, Knoop H, Bassez G, et al. Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1. Neurol Genet. 2021;7(2):e572. https:\/\/doi.org\/10.1212\/nxg.0000000000000572.","journal-title":"Neurol Genet"},{"issue":"7","key":"5180_CR42","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/brain\/awz115","volume":"142","author":"M Flower","year":"2019","unstructured":"Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F, Lo K, Hensman Moss D, Jones L, Holmans P, Investigators T-H, et al. MSH3 modifies somatic instability and disease severity in Huntington\u2019s and myotonic dystrophy type 1. Brain. 2019;142(7):1876\u201386. https:\/\/doi.org\/10.1093\/brain\/awz115.","journal-title":"Brain"},{"issue":"3","key":"5180_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ajhg.2017.01.033","volume":"100","author":"L Barbe","year":"2017","unstructured":"Barbe L, Lanni S, Lopez-Castel A, Franck S, Spits C, Keymolen K, Seneca S, Tome S, Miron I, Letourneau J, et al. CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy. Am J Hum Genet. 2017;100(3):488\u2013505. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.033.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"5180_CR44","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1212\/NXG.0000000000000338","volume":"5","author":"C Legare","year":"2019","unstructured":"Legare C, Overend G, Guay SP, Monckton DG, Mathieu J, Gagnon C, Bouchard L. DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1. Neurol Genet. 2019;5(3):e338. https:\/\/doi.org\/10.1212\/NXG.0000000000000338.","journal-title":"Neurol Genet"},{"issue":"4","key":"5180_CR45","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00415-012-6740-y","volume":"260","author":"V Huin","year":"2013","unstructured":"Huin V, Vasseur F, Schraen-Maschke S, Dhaenens CM, Devos P, Dupont K, Sergeant N, Buee L, Lacour A, Hofmann-Radvanyi H, et al. MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1. J Neurol. 2013;260(4):998\u20131003. https:\/\/doi.org\/10.1007\/s00415-012-6740-y.","journal-title":"J Neurol"},{"issue":"3","key":"5180_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nmd.2018.12.002","volume":"29","author":"AM Hawkins","year":"2019","unstructured":"Hawkins AM, Hawkins CL, Abdul Razak K, Khoo TK, Tran K, Jackson RV. Respiratory dysfunction in myotonic dystrophy type 1: A systematic review. Neuromuscul Disord. 2019;29(3):198\u2013212. https:\/\/doi.org\/10.1016\/j.nmd.2018.12.002.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"5180_CR47","first-page":"414","volume":"54","author":"T Ashizawa","year":"1994","unstructured":"Ashizawa T, Anvret M, Baiget M, Barcelo JM, Brunner H, Cobo AM, Dallapiccola B, Jr. Fenwick RG, Grandell U, Harley H, et al., et al. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet. 1994;54(3):414\u201323.","journal-title":"Am J Hum Genet"},{"issue":"24","key":"5180_CR48","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1212\/WNL.0b013e3181c677e1","volume":"73","author":"J Puymirat","year":"2009","unstructured":"Puymirat J, Giguere Y, Mathieu J, Bouchard JP. Intergenerational contraction of the CTG repeats in 2 families with myotonic dystrophy type 1. Neurology. 2009;73(24):2126\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c677e1.","journal-title":"Neurology"},{"key":"5180_CR49","doi-asserted-by":"publisher","unstructured":"Russo V, Capolongo A, Bottino R, Carbone A, Palladino A, Liccardo B, Nigro G, Marchel M, Golino P, D\u2019Andrea A. Echocardiographic features of cardiac involvement in myotonic dystrophy 1: prevalence and prognostic value. J Clin Med. 2023;12(5). https:\/\/doi.org\/10.3390\/jcm12051947.","DOI":"10.3390\/jcm12051947"},{"issue":"Pt 6","key":"5180_CR50","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1042\/bst0371281","volume":"37","author":"JE Lee","year":"2009","unstructured":"Lee JE, Cooper TA. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans. 2009;37(Pt 6):1281\u20136. https:\/\/doi.org\/10.1042\/bst0371281.","journal-title":"Biochem Soc Trans"},{"issue":"5364","key":"5180_CR51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.280.5364.737","volume":"280","author":"AV Philips","year":"1998","unstructured":"Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science. 1998;280(5364):737\u201341. https:\/\/doi.org\/10.1126\/science.280.5364.737.","journal-title":"Science"},{"issue":"1","key":"5180_CR52","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1038\/s41598-022-07820-1","volume":"12","author":"G Labayru","year":"2022","unstructured":"Labayru G, Camino B, Jimenez-Marin A, Garmendia J, Villanua J, Zulaica M, Cortes JM, Lopez de Munain A, Sistiaga A. White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study. Sci Rep. 2022;12(1):3988. https:\/\/doi.org\/10.1038\/s41598-022-07820-1.","journal-title":"Sci Rep"},{"issue":"12","key":"5180_CR53","doi-asserted-by":"publisher","first-page":"e0208620","DOI":"10.1371\/journal.pone.0208620","volume":"13","author":"H Kim","year":"2018","unstructured":"Kim H, Lim YM, Oh YJ, Lee EJ, Kim KK. Comparison of brain magnetic resonance imaging between myotonic dystrophy type 1 and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. PLoS ONE. 2018;13(12):e0208620. https:\/\/doi.org\/10.1371\/journal.pone.0208620.","journal-title":"PLoS ONE"},{"issue":"15","key":"5180_CR54","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/hmg\/ddaa123","volume":"29","author":"F Morales","year":"2020","unstructured":"Morales F, Vasquez M, Corrales E, Vindas-Smith R, Santamaria-Ulloa C, Zhang B, Sirito M, Estecio MR, Krahe R, Monckton DG. Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset. Hum Mol Genet. 2020;29(15):2496\u2013507. https:\/\/doi.org\/10.1093\/hmg\/ddaa123.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05180-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05180-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05180-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:02:05Z","timestamp":1792011725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05180-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5180"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05180-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine. It was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"647"}}